RE:RE:RE:RE:RE:RE:RE:RE:RE:No news , no leaks?,,my best guess is there is complacency and infighting among the insiders and management. Hepa wants the operation to fail in order to pick us up at a stink pricing,,,,they are probably using a 3rd party short,,,exchange regulators are not interested,,,our team is in a pickle as to how to push forward,,,,,no other pharma seems willing to be in business with the insiders and weak management unless major change is made,,,the team are refusing to give up their golden goose. No trials in China or the Asian block is telling!,,,all interested parties we were told about have backed out of the deal offerings,,,the added failures over the years have caught up to pinocchio,,,we are between a rock and a hard place,,,,,no matter what the C19 trial data tells us there will be very limited excitement from the market. The managemnt team has continued to fail month after month since BoM results. The market respects accomplishments. The C19 trial which was supposed to be run last year with first data out by end of April/May is still in disarray. Again,,,,this company is seen as a personal banking system for management. Presentations still mirror what was said 5 years ago. The business world outside is way ahead of anything our team can dream up.